Page 113 - Read Online
P. 113

Oo et al. Mini-invasive Surg 2019;3:13                         Mini-invasive Surgery
               DOI: 10.20517/2574-1225.2019.02




               Commentary                                                                    Open Access


               Overview of gastroesophageal junction cancers

               Aung Myint Oo, Saleem Ahmed

               Department of General Surgery, Tan Tock Seng Hospital, Singapore 308433, Singapore.

               Correspondence to: Dr. Saleem Ahmed, Department of General Surgery, Tan Tock Seng Hospital, Singapore 308433,
               Singapore. E-mail: medicsaleem@gmail.com; Dr. Aung Myint Oo, Department of General Surgery, Tan Tock Seng Hospital,
               Singapore 308433, Singapore.  E-mail: myint_oo_aung@ttsh.com.sg

               How to cite this article: Oo AM, Ahmed S. Overview of gastroesophageal junction cancers. Mini-invasive Surg 2019;3:13.
               http://dx.doi.org/10.20517/2574-1225.2019.02

               Received: 14 Jan 2019    First Decision: 25 Mar 2019     Revised: 10 Apr 2019     Accepted: 17 Apr 2019      Published: 6 May 2019
               Science Editor: Tetsu Fukunaga    Copy Editor: Cai-Hong Wang    Production Editor: Huan-Liang Wu



               Abstract
               Oesophageal and gastroesophageal junction (GEJ) malignancy is the fastest growing cancer in the Western population.
               This together with the deadly nature of the disease has attracted increased attention from doctors and researchers alike.
               The increasing incidence has been primarily attributed to the increase in rates of obesity that in turn causes increased
               gastroesophageal reflux disease leading to Barrett’s oesophagus and eventually adenocarcinoma of the oesophagus
               especially at the GEJ. We discuss the epidemiology, risk factors and the management of GEJ tumours.

               Keywords: Cardioesophageal, gastroesophageal, upper gastrointestinal, cancer, tumour



               INTRODUCTION
               Oesophageal and gastroesophageal junction (GEJ) malignancy is the fastest growing cancer in the Western
               population, especially in United States of America (USA), rising by 6-fold annually on the background of
                                               [1,2]
               declining rates of most other cancers . This together with the deadly nature of the disease has attracted
               increased attention from doctors and researchers alike. The increasing incidence has been primarily
               attributed to the increase in rates of obesity that in turn causes increased gastroesophageal reflux disease
               (GERD) leading to Barrett’s oesophagus and eventually adenocarcinoma of the oesophagus especially at
                      [3]
               the GEJ .

               DEFINITION
               The definition of GEJ cancers has been an area of controversy and disagreement and have in the past
               been considered either a gastric or oesophageal cancer as they lie in between the two. GEJ tumours also

                           © The Author(s) 2019. Open Access This article is licensed under a Creative Commons Attribution 4.0
                           International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
                sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long
                as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license,
                and indicate if changes were made.


                                                                                                                                                    www.misjournal.net
   108   109   110   111   112   113   114   115   116   117   118